Alternatives to Tarsier Pharma

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Global eye health company offering contact lenses, lens care, supplements, and prescription pharmaceuticals.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.